CSF1R and neoplasm: Inhibition of CSF1 receptor (CSFR) by small molecule (BLZ945) has demonstrated anti-tumor effects in glioma and breast cancer models through loss of M2 polarized macrophages and enhancement of T-cell recruitment to the tumor (Pyonteck et al., 2013; Strachan et al., 2013).